会員登録
ログイン
【4502】武田薬品工業
製薬。中枢神経、消化器。本社は大阪市。
類似企業：
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2025/01/30 | Q3予 | 4,590,000 | ↑ | 344,000 | ↑ | 162,000 | ↑ | 118,000 | ↑ |
| 2025.03 | 2024/10/31 | Q2予 | 4,480,000 | ↑ | 265,000 | ↑ | 93,000 | ↑ | 68,000 | ↑ |
| 2025.03 | 2024/07/31 | Q1予 | 4,350,000 | → | 225,000 | → | 55,000 | → | 58,000 | → |
| 2025.03 | 2024/05/09 | 当初予 | 4,350,000 | - | 225,000 | - | 55,000 | - | 58,000 | - |
| 2024.03 | 2024/05/09 | 実 | 4,263,762 | ↑ | 214,075 | ↓ | 52,791 | ↓ | 144,067 | ↑ |
| 2024.03 | 2024/02/01 | Q3予 | 3,980,000 | → | 225,000 | → | 70,000 | → | 93,000 | → |
| 2024.03 | 2023/10/26 | Q2予 | 3,980,000 | ↑ | 225,000 | ↓ | 70,000 | ↓ | 93,000 | ↓ |
| 2024.03 | 2023/07/27 | Q1予 | 3,840,000 | → | 349,000 | → | 185,000 | → | 142,000 | → |
| 2024.03 | 2023/05/11 | 当初予 | 3,840,000 | - | 349,000 | - | 185,000 | - | 142,000 | - |
| 2023.03 | 2023/05/11 | 実 | 4,027,478 | ↑ | 490,505 | ↓ | 375,090 | ↓ | 317,017 | ↑ |
| 2023.03 | 2023/02/02 | Q3予 | 3,930,000 | → | 530,000 | → | 426,000 | → | 307,000 | → |
| 2023.03 | 2022/10/27 | Q2予 | 3,930,000 | ↑ | 530,000 | ↑ | 426,000 | ↑ | 307,000 | ↑ |
| 2023.03 | 2022/07/28 | Q1予 | 3,690,000 | → | 520,000 | → | 411,000 | → | 292,000 | → |
| 2023.03 | 2022/05/11 | 当初予 | 3,690,000 | - | 520,000 | - | 411,000 | - | 292,000 | - |
| 2022.03 | 2022/05/11 | 実 | 3,569,006 | ↑ | 460,844 | ↓ | 302,571 | ↓ | 230,059 | ↓ |
| 2022.03 | 2022/02/03 | Q3予 | 3,510,000 | ↑ | 515,000 | ↑ | 385,000 | ↑ | 242,500 | ↑ |
| 2022.03 | 2021/10/28 | Q2予 | 3,370,000 | → | 488,000 | → | 352,000 | → | 184,300 | ↓ |
| 2022.03 | 2021/07/30 | Q1予 | 3,370,000 | → | 488,000 | → | 352,000 | → | 250,000 | → |
| 2022.03 | 2021/05/11 | 当初予 | 3,370,000 | - | 488,000 | - | 352,000 | - | 250,000 | - |
| 2021.03 | 2021/05/11 | 実 | 3,197,812 | ↓ | 509,269 | ↑ | 366,235 | ↑ | 376,005 | ↑ |
| 2021.03 | 2021/02/04 | Q3予 | 3,200,000 | → | 434,000 | → | 258,000 | → | 180,500 | ↑ |
| 2021.03 | 2020/10/29 | Q2予 | 3,200,000 | ↓ | 434,000 | ↑ | 258,000 | ↑ | 124,000 | ↑ |
| 2021.03 | 2020/07/31 | Q1予 | 3,250,000 | → | 395,000 | ↑ | 230,000 | ↑ | 92,000 | ↑ |
| 2021.03 | 2020/05/13 | 当初予 | 3,250,000 | - | 355,000 | - | 200,000 | - | 60,000 | - |
| 2020.03 | 2020/05/13 | 実 | 3,291,188 | ↑ | 100,408 | ↑ | -60,754 | ↑ | 44,241 | ↑ |
| 2020.03 | 2020/02/04 | Q3予 | 3,286,000 | ↑ | 10,000 | ↑ | -140,000 | ↑ | -162,000 | ↑ |
| 2020.03 | 2019/10/31 | Q2予 | 3,260,000 | ↓ | -110,000 | ↑ | -290,000 | ↑ | -273,000 | ↑ |
| 2020.03 | 2019/07/31 | Q1予 | 3,300,000 | → | -166,000 | ↑ | -342,000 | ↑ | -367,700 | ↑ |
| 2020.03 | 2019/05/14 | 当初予 | 3,300,000 | - | -193,000 | - | -369,000 | - | -383,000 | - |
| 2019.03 | 2019/05/14 | 実 | 2,097,224 | ↑ | 204,969 | ↓ | 94,896 | ↓ | 109,126 | ↓ |
| 2019.03 | 2019/04/25 | 修正予 | 2,097,000 | ↑ | 205,000 | ↓ | 95,000 | ↓ | - | - |
| 2019.03 | 2019/02/01 | Q3予 | 1,750,000 | → | 268,900 | → | 245,200 | → | 189,500 | → |
| 2019.03 | 2018/10/31 | Q2予 | 1,750,000 | ↑ | 268,900 | ↑ | 245,200 | ↑ | 189,500 | ↑ |
| 2019.03 | 2018/07/31 | Q1予 | 1,737,000 | → | 201,000 | → | 183,000 | → | 139,000 | → |
| 2019.03 | 2018/05/14 | 当初予 | 1,737,000 | - | 201,000 | - | 183,000 | - | 139,000 | - |
| 2018.03 | 2018/05/14 | 実 | 1,770,531 | ↑ | 241,789 | ↑ | 217,205 | ↑ | 186,886 | ↑ |
| 2018.03 | 2018/02/01 | Q3予 | 1,745,000 | ↑ | 218,700 | ↑ | 193,000 | ↓ | 157,300 | ↑ |
| 2018.03 | 2017/11/01 | Q2予 | 1,720,000 | ↑ | 200,000 | ↑ | 210,000 | ↑ | 152,000 | ↑ |
| 2018.03 | 2017/07/28 | Q1予 | 1,680,000 | → | 180,000 | → | 190,000 | → | 138,000 | → |
| 2018.03 | 2017/05/10 | 当初予 | 1,680,000 | - | 180,000 | - | 190,000 | - | 138,000 | - |
| 2017.03 | 2017/05/10 | 実 | 1,732,051 | ↑ | 155,867 | ↑ | 143,346 | ↑ | 114,940 | ↑ |
| 2017.03 | 2017/02/01 | Q3予 | 1,700,000 | ↑ | 135,000 | → | 132,500 | → | 93,000 | ↑ |
| 2017.03 | 2016/10/28 | Q2予 | 1,670,000 | ↓ | 135,000 | → | 132,500 | → | 91,000 | ↑ |
| 2017.03 | 2016/07/29 | Q1予 | 1,720,000 | → | 135,000 | → | 132,500 | → | 88,000 | → |
| 2017.03 | 2016/05/10 | 当初予 | 1,720,000 | - | 135,000 | - | 132,500 | - | 88,000 | - |
| 2016.03 | 2016/05/10 | 実 | 1,807,378 | ↓ | 130,828 | ↑ | 120,539 | ↑ | 80,166 | ↑ |
| 2016.03 | 2016/02/03 | Q3予 | 1,820,000 | → | 120,000 | ↑ | 115,000 | → | 68,000 | → |
| 2016.03 | 2015/10/30 | Q2予 | 1,820,000 | → | 105,000 | → | 115,000 | → | 68,000 | → |
| 2016.03 | 2015/07/30 | Q1予 | 1,820,000 | → | 105,000 | → | 115,000 | → | 68,000 | → |
| 2016.03 | 2015/05/15 | 当初予 | 1,820,000 | - | 105,000 | - | 115,000 | - | 68,000 | - |
| 2015.03 | 2015/05/15 | 実 | 1,777,824 | ↑ | -129,254 | ↑ | -145,437 | ↓ | -145,775 | ↓ |
| 2015.03 | 2015/04/29 | 修正予 | 1,775,000 | ↑ | -130,000 | ↓ | -145,000 | ↓ | -145,000 | ↓ |
| 2015.03 | 2015/02/05 | Q3予 | 1,725,000 | → | 170,000 | ↑ | 160,000 | ↑ | 65,000 | ↓ |
| 2015.03 | 2014/10/30 | Q2予 | 1,725,000 | → | 150,000 | → | 140,000 | → | 85,000 | → |
| 2015.03 | 2014/08/01 | Q1予 | 1,725,000 | → | 150,000 | → | 140,000 | → | 85,000 | → |
| 2015.03 | 2014/05/08 | 当初予 | 1,725,000 | - | 150,000 | - | 140,000 | - | 85,000 | - |
| 2014.03 | 2014/05/08 | 実 | 1,691,685 | - | 139,274 | - | 158,851 | - | 106,658 | - |
